Data / Drug companies / Walmart Inc.
Walmart Inc.: 345 products in the FDA NDC directory, labeler code 79903
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Walmart Inc. (labeler code 79903) lists 345 products in the FDA National Drug Code Directory, covering 170 finished drugs by generic name. By type: 345 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 1, 2026.
The request: Watch Walmart Inc. (FDA labeler code 79903): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 79903
- Products in commercial distribution
- 345
- Packages
- 451
- Finished drugs by generic name
- 170
- Prescription products
- 0
- Over the counter products
- 345
- Flagged as original packager
- 322 of 322 products that carry the flag
- Started marketing in the last 12 months
- 54
- Products with a marketing end date set
- 20
- Earliest marketing start
- January 12, 2012
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 256 | 74.2% |
| Generic drugs (ANDA) | 81 | 23.5% |
| Unapproved homeopathic products | 5 | 1.4% |
| Other unapproved drugs | 2 | 0.6% |
| New drug applications (NDA) | 1 | 0.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 345 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 34 | 9.9% |
| Liquid | 28 | 8.1% |
| Tablet, film coated | 26 | 7.5% |
| Solution | 22 | 6.4% |
| Lotion | 20 | 5.8% |
| Cream | 19 | 5.5% |
| Spray | 16 | 4.6% |
| Tablet, chewable | 15 | 4.3% |
| Gel | 14 | 4.1% |
| Capsule, liquid filled | 14 | 4.1% |
| Lozenge | 14 | 4.1% |
| Solution/ drops | 11 | 3.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Olopatadine Hydrochloride Ophthalmic Solution | 79903-450 | Solution/ drops | Generic drugs (ANDA) | November 1, 2026 |
| Equate | 79903-441 | Tablet | Generic drugs (ANDA) | November 1, 2026 |
| Equate nicotine | 79903-354 | Lozenge | Generic drugs (ANDA) | September 11, 2026 |
| Regular Strength Stomach Relief | 79903-443 | Suspension | Over the counter monograph drugs | August 20, 2026 |
| Equate allergy relief d | 79903-424 | Tablet, film coated, extended release | Generic drugs (ANDA) | August 6, 2026 |
| Equate nicotine | 79903-353 | Lozenge | Generic drugs (ANDA) | July 13, 2026 |
| Equate Nighttime Vapor Ice Cold and Flu | 79903-418 | Tablet, film coated | Over the counter monograph drugs | July 8, 2026 |
| Equate Daytime Nighttime Vapor Ice Cold and Flu | 79903-417 | Kit | Over the counter monograph drugs | July 8, 2026 |
| Equate Daytime Vapor Ice Cold and Flu | 79903-416 | Tablet, film coated | Over the counter monograph drugs | July 8, 2026 |
| Equate Severe Cold Cough and Flu | 79903-356 | Powder, for solution | Over the counter monograph drugs | June 16, 2026 |
| Equate Severe Cold and Flu | 79903-355 | Powder, for solution | Over the counter monograph drugs | June 16, 2026 |
| Cold and Flu Daytime, Nighttime | 79903-432 | Kit | Over the counter monograph drugs | June 9, 2026 |
| Childrens Allergy Relief | 79903-411 | Solution | Over the counter monograph drugs | May 26, 2026 |
| Childrens Cough and Congestion, Childrens Cold and Cough Day, Night | 79903-414 | Kit | Over the counter monograph drugs | May 19, 2026 |
| Allergy Plus Headache Relief | 79903-434 | Tablet, film coated | Over the counter monograph drugs | May 18, 2026 |
| Cold and Flu | 79903-433 | Tablet, film coated | Over the counter monograph drugs | May 14, 2026 |
| Walmart equate sunscreen spf 50 sport broad spectrum | 79903-379 | Spray | Over the counter monograph drugs | May 5, 2026 |
| Cold Sore Fever Blister Treatment | 79903-435 | Cream | Generic drugs (ANDA) | May 1, 2026 |
| Equate pain relief | 79903-422 | Liquid | Over the counter monograph drugs | April 29, 2026 |
| Equate pain relief pm | 79903-421 | Solution | Over the counter monograph drugs | April 29, 2026 |
| Equate menstrual pain relief | 79903-420 | Tablet, film coated, extended release | Generic drugs (ANDA) | April 29, 2026 |
| Menstrual Bloat Relief | 79903-425 | Tablet, film coated | Over the counter monograph drugs | April 7, 2026 |
| All Day Allergy Relief | 79903-437 | Tablet | Generic drugs (ANDA) | April 1, 2026 |
| Equate Lidocaine and Menthol Paraben Free | 79903-030 | Patch | Over the counter monograph drugs | April 1, 2026 |
| Zinc oxide, Dimethicone | 79903-431 | Spray | Over the counter monograph drugs | March 31, 2026 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.